107 related articles for article (PubMed ID: 10417175)
21.
Bone MA; Wilk AJ; Perault AI; Marlatt SA; Scheller EV; Anthouard R; Chen Q; Stibitz S; Cotter PA; Julio SM
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1519-E1527. PubMed ID: 28167784
[TBL] [Abstract][Full Text] [Related]
22. Long time immunogenicity of measles vaccine in the vaccination era: An open question.
Gallone MS; Germinario C; Larocca A; Tafuri S
Hum Vaccin Immunother; 2017 Jan; 13(1):117-119. PubMed ID: 27668886
[TBL] [Abstract][Full Text] [Related]
23. Rediscovering Pertussis.
Zlamy M
Front Pediatr; 2016; 4():52. PubMed ID: 27376050
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults.
Gröndahl-Yli-Hannuksela K; Vahlberg T; Ilonen J; Mertsola J; He Q
Immunogenetics; 2016 Oct; 68(9):733-41. PubMed ID: 27282930
[TBL] [Abstract][Full Text] [Related]
25. Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.
Scheller EV; Cotter PA
Pathog Dis; 2015 Nov; 73(8):ftv079. PubMed ID: 26416077
[TBL] [Abstract][Full Text] [Related]
26. Waning and aging of cellular immunity to Bordetella pertussis.
van Twillert I; Han WG; van Els CA
Pathog Dis; 2015 Nov; 73(8):ftv071. PubMed ID: 26371178
[TBL] [Abstract][Full Text] [Related]
27. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
28. Characterization of co-purified acellular pertussis vaccines.
Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
[TBL] [Abstract][Full Text] [Related]
29. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
Fadugba OO; Wang L; Chen Q; Halasa NB
Clin Vaccine Immunol; 2014 Dec; 21(12):1613-9. PubMed ID: 25253666
[TBL] [Abstract][Full Text] [Related]
30. Prediction of virulence factors using bioinformatics approaches.
Chaudhuri R; Ramachandran S
Methods Mol Biol; 2014; 1184():389-400. PubMed ID: 25048137
[TBL] [Abstract][Full Text] [Related]
31. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
Ausiello CM; Cassone A
mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
[TBL] [Abstract][Full Text] [Related]
32. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
33. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response.
Rieber N; Graf A; Hartl D; Urschel S; Belohradsky BH; Liese J
PLoS One; 2011 Mar; 6(3):e17271. PubMed ID: 21408149
[TBL] [Abstract][Full Text] [Related]
34. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.
Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP
Clin Vaccine Immunol; 2009 Sep; 16(9):1344-51. PubMed ID: 19625486
[TBL] [Abstract][Full Text] [Related]
35. Visiting sick people: is it really detrimental to our health?
Fouchet D; O'Brien J; Pontier D
PLoS One; 2008 Jun; 3(6):e2299. PubMed ID: 18523551
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.
Banus S; Bottema RW; Siezen CL; Vandebriel RJ; Reimerink J; Mommers M; Koppelman GH; Hoebee B; Thijs C; Postma DS; Kimman TG; Stelma FF
Clin Vaccine Immunol; 2007 Oct; 14(10):1377-80. PubMed ID: 17699831
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
38. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.
Meyer CU; Zepp F; Decker M; Lee M; Chang SJ; Ward J; Yoder S; Bogaert H; Edwards KM
Clin Vaccine Immunol; 2007 Mar; 14(3):288-92. PubMed ID: 17267589
[TBL] [Abstract][Full Text] [Related]
39. Relationship between maternal and child cytokine responses to allergen and phytohaemagglutinin 2 years after delivery.
Larsson AK; Nilsson C; Höglind A; Sverremark-Ekström E; Lilja G; Troye-Blomberg M
Clin Exp Immunol; 2006 Jun; 144(3):401-8. PubMed ID: 16734608
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory.
Upham JW; Rate A; Rowe J; Kusel M; Sly PD; Holt PG
Infect Immun; 2006 Feb; 74(2):1106-12. PubMed ID: 16428758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
